Market Tracker

03/05 6:02pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

During the Trading Day
1.70 +0.08 / +4.94%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.84 +0.14 / +8.24%
 
Volume: 3.5K

Today’s Trading

Previous close1.62
Today’s open1.80
Day’s range1.69 - 1.84
Volume1,767,093
Average volume (3 months)1,025,546
Market cap$244.2M
Dividend yield--
Data as of 4:03pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+30.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc+0.51+4.82%
VTAEVitae Pharmaceutical...+0.07+0.63%
GALEGalena Biopharma Inc+0.05+2.56%
CARACara Therapeutics In...+0.18+1.73%
Data as of 3:59pm ET, 03/05/2015

Financials

Last reporting dateMarch 5, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts